Screener
NeoGenomics NEO Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | (unaudited)June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accrued expenses and other liabilities | 23,045 | 11,975 |
| Current portion of operating lease liabilities | 3,722 | 4,776 |
| Current portion of finance lease liabilities | 1,704 | 28 |
| Contract liabilities | 194 | 851 |
| Total current liabilities | 105,883 | 88,300 |
| Long-term liabilities | ||
| Operating lease liabilities | 64,671 | 62,822 |
| Finance lease liabilities | 4,030 | 27 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's deferred revenue?
- NeoGenomics (NEO) reported deferred revenue of $194K in Q2 2026.
- How has NeoGenomics's deferred revenue changed year-over-year?
- NeoGenomics's deferred revenue decreased by 82.1% year-over-year, from $1.08M to $194K.
- What is the long-term trend for NeoGenomics's deferred revenue?
- Over 5 years (2020 to 2025), NeoGenomics's deferred revenue has grown at a -26.7% compound annual growth rate (CAGR), from $4.03M to $851K.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.
Ask your AI about NeoGenomics's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude